The European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Vertex Pharmaceuticals' Kalydeco (ivacaftor) to treat the underlying cause of cystic fibrosis (CF). Kalydeco is indicated for people ...
Tags: Kalydeco, cystic fibrosis, clinical study